FDA Announces Public Comment Period for Proposed Collection of Biological Product Sample Protocols

Summary

The Food and Drug Administration (FDA) is seeking public input on its proposed collection of information related to biological product sample protocols, as required by the Paperwork Reduction Act of 1995, and invites comments on the proposed extension of this existing collection for 60 days.